Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Income towards Parent Company (2019 - 2025)

Pulmonx (LUNG) has disclosed Income towards Parent Company for 7 consecutive years, with -$13.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Income towards Parent Company rose 1.58% to -$13.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$56.7 million, a 0.78% increase, with the full-year FY2024 number at -$56.4 million, up 7.31% from a year prior.
  • Income towards Parent Company was -$13.9 million for Q3 2025 at Pulmonx, up from -$15.2 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of -$10.2 million in Q3 2021 to a low of -$16.2 million in Q2 2023.
  • A 5-year average of -$14.1 million and a median of -$14.2 million in 2022 define the central range for Income towards Parent Company.
  • Peak YoY movement for Income towards Parent Company: crashed 163.76% in 2021, then grew 13.31% in 2024.
  • Pulmonx's Income towards Parent Company stood at -$13.0 million in 2021, then dropped by 9.82% to -$14.3 million in 2022, then increased by 2.6% to -$13.9 million in 2023, then grew by 5.56% to -$13.1 million in 2024, then dropped by 6.03% to -$13.9 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Income towards Parent Company are -$13.9 million (Q3 2025), -$15.2 million (Q2 2025), and -$14.4 million (Q1 2025).